Evidence map›Paper›PMID 37908988›Full record

ArticleJCEM case reports2023

Rare Case of Pseudohypoparathyroidism With Normocalcemia Because of a Novel GNAS Mutation.

Goutami Mangu, Sonika Malik, Vijay Eranki

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in JCEM case reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Goutami ManguDepartment of Internal Medicine, Texas Tech University Health Sciences Center, Odessa, TX 79765, USA.ORCID https://orcid.org/0000-0002-6376-0272
Sonika MalikDepartment of Endocrinology, Diabetes and Metabolism, Texas Tech University Health Science Center, Odessa, TX 79765, USA.ORCID https://orcid.org/0000-0001-5332-4680
Vijay ErankiDepartment of Endocrinology, Diabetes and Metabolism, Texas Tech University Health Science Center, Odessa, TX 79765, USA.ORCID https://orcid.org/0000-0002-6483-9775
Texas Tech University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PTH resistance is characterized by hypocalcemia and hyperphosphatemia in the presence of elevated PTH concentrations, resulting in pseudohypoparathyroidism, which is subdivided into different types according to its different pathogenesis and phenotype. PTH receptor is the alpha subunit of stimulatory G protein (G

Indexed as

Albright hereditary osteodystrophyalpha stimulating activity polypeptide pathogenic variantsguanine nucleotide binding proteinparathyroid hormonepseudohypoparathyroidism

Identifiers

PMID37908988
PMCPMC10580659
OpenAlexW4385710003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.